Physician profile
James D Lowery
NPI 1861492506
$565.25
in general payments reported to CMS, 2019-2025
7 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $12.07 · 2024: $93.64 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $334.78 | 2019-2025 | |
| Abbvie INC. | $118.80 | 2024-2025 | |
| Mindray Ds USA, INC. | $33.86 | 2024 | A7 Anesthesia System |
| Stryker Corporation | $29.45 | 2019-2025 | Audion Et Dilation System |
| Astrazeneca Pharmaceuticals LP | $21.71 | 2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $13.56 | 2025 | Xhance |
| Genzyme Corporation | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.